Moreover, JFK is up-regulated in liver tissues from NAFLD patients (n = 206) as compared with healthy controls (n = 10) according to a recently published public dataset (GSE135251) (Govaere et al., 2020). Here, FBXO42 is linked to metabolic dysfunction-associated steatotic liver disease.